Professor Xavier Dray’s role as Adjunct Professor at SDU and SATC·C lends international credibility and academic prestige to our institution.
His affiliation underscores the scientific strength and global reach of SATC·C, reinforcing its status as a leading research centre in minimally invasive GI diagnostics and CRC prevention.
Maya Thanou
Dr. Maya Thanou joins us as Adjunct Professor with a strong background in pharmaceutical nanotechnology and translational research.
Her expertise in targeted imaging and drug delivery will support the development of minimally invasive techniques and improve perioperative diagnostics.
She will play a key role in strengthening our research environment, mentoring young researchers, and linking our department with international collaborators.
Dr. Maya Thanou’s presence enhances both our academic depth and our clinical innovation capacity.
Angus Watson
Angus brings extensive expertise in colon capsule endoscopy (CCE) and digital health innovation.
His leadership in large-scale CCE studies, such as the CAP ACCESS study, and active participation in international collaborations like the iCARE group, enhance our department’s research capabilities and global reach.
By integrating AI-driven diagnostics and minimally invasive technologies, Professor Watson contributes to the advancement of patient-centred care and the development of innovative diagnostic tools.
His involvement also strengthens our educational programs, providing mentorship and fostering a culture of excellence in surgical research.
Robert Steele
Professor Robert Steele’s adjunctship brings internationally recognised expertise in colorectal cancer screening and prevention to our unit.
His involvement strengthens our research into early detection, non-invasive diagnostics, and population-based screening strategies.
He provides valuable mentorship to clinical researchers and contributes to the design and interpretation of high-quality studies.
His presence directly enhances the unit’s academic standing and supports our mission to lead in translational cancer research.